A citation-based method for searching scientific literature

T Dent, J Jbilou, I Rafi, N Segnan, S Törnberg, S Chowdhury, A Hall, G Lyratzopoulos, R Eeles, D Eccles, N Hallowell, N Pashayan, P Pharoah, H Burton. Public Health Genomics 2013
Times Cited: 38







List of co-cited articles
171 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Incorporating genomics into breast and prostate cancer screening: assessing the implications.
Susmita Chowdhury, Tom Dent, Nora Pashayan, Alison Hall, Georgios Lyratzopoulos, Nina Hallowell, Per Hall, Paul Pharoah, Hilary Burton. Genet Med 2013
61
44


Implementing risk-stratified screening for common cancers: a review of potential ethical, legal and social issues.
A E Hall, S Chowdhury, N Hallowell, N Pashayan, T Dent, P Pharoah, H Burton. J Public Health (Oxf) 2014
31
38

Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model.
Nora Pashayan, Steve Morris, Fiona J Gilbert, Paul D P Pharoah. JAMA Oncol 2018
117
31

Adjusting the frequency of mammography screening on the basis of genetic risk: Attitudes among women in the UK.
Susanne F Meisel, Nora Pashayan, Belinda Rahman, Lucy Side, Lindsay Fraser, Sue Gessler, Anne Lanceley, Jane Wardle. Breast 2015
35
31

Polygenic susceptibility to prostate and breast cancer: implications for personalised screening.
N Pashayan, S W Duffy, S Chowdhury, T Dent, H Burton, D E Neal, D F Easton, R Eeles, P Pharoah. Br J Cancer 2011
121
26

Public health implications from COGS and potential for risk stratification and screening.
Hilary Burton, Susmita Chowdhury, Tom Dent, Alison Hall, Nora Pashayan, Paul Pharoah. Nat Genet 2013
92
23

Breast cancer risk feedback to women in the UK NHS breast screening population.
D Gareth R Evans, Louise S Donnelly, Elaine F Harkness, Susan M Astley, Paula Stavrinos, Sarah Dawe, Donna Watterson, Lynne Fox, Jamie C Sergeant, Sarah Ingham,[...]. Br J Cancer 2016
48
23

Public interest in and acceptability of the prospect of risk-stratified screening for breast and prostate cancer.
Marie Koitsalu, Mirjam A G Sprangers, Martin Eklund, Kamila Czene, Per Hall, Henrik Grönberg, Yvonne Brandberg. Acta Oncol 2016
26
30

Polygenes, risk prediction, and targeted prevention of breast cancer.
Paul D P Pharoah, Antonis C Antoniou, Douglas F Easton, Bruce A J Ponder. N Engl J Med 2008
403
18

Women's decision-making regarding risk-stratified breast cancer screening and prevention from the perspective of international healthcare professionals.
Linda Rainey, Daniëlle van der Waal, Louise S Donnelly, D Gareth Evans, Yvonne Wengström, Mireille Broeders. PLoS One 2018
18
38

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.
Rosalind A Eeles, Ali Amin Al Olama, Sara Benlloch, Edward J Saunders, Daniel A Leongamornlert, Malgorzata Tymrakiewicz, Maya Ghoussaini, Craig Luccarini, Joe Dennis, Sarah Jugurnauth-Little,[...]. Nat Genet 2013
416
15

Large-scale genotyping identifies 41 new loci associated with breast cancer risk.
Kyriaki Michailidou, Per Hall, Anna Gonzalez-Neira, Maya Ghoussaini, Joe Dennis, Roger L Milne, Marjanka K Schmidt, Jenny Chang-Claude, Stig E Bojesen, Manjeet K Bolla,[...]. Nat Genet 2013
787
15


Personalized early detection and prevention of breast cancer: ENVISION consensus statement.
Nora Pashayan, Antonis C Antoniou, Urska Ivanus, Laura J Esserman, Douglas F Easton, David French, Gaby Sroczynski, Per Hall, Jack Cuzick, D Gareth Evans,[...]. Nat Rev Clin Oncol 2020
63
15


Prevention of breast cancer in the context of a national breast screening programme.
A Howell, S Astley, J Warwick, P Stavrinos, S Sahin, S Ingham, H McBurney, B Eckersley, M Harvie, M Wilson,[...]. J Intern Med 2012
21
23

Population-based, risk-stratified genetic testing for ovarian cancer risk: a focus group study.
S F Meisel, L Side, L Fraser, S Gessler, J Wardle, A Lanceley. Public Health Genomics 2013
22
22

Assessing and managing breast cancer risk: clinicians' current practice and future needs.
Ian M Collins, Emma Steel, G Bruce Mann, Jon D Emery, Adrian Bickerstaffe, Alison Trainer, Phyllis Butow, Marie Pirotta, Antonis C Antoniou, Jack Cuzick,[...]. Breast 2014
32
15

Cost-effectiveness and harm-benefit analyses of risk-based screening strategies for breast cancer.
Ester Vilaprinyo, Carles Forné, Misericordia Carles, Maria Sala, Roger Pla, Xavier Castells, Laia Domingo, Montserrat Rue. PLoS One 2014
90
13

Are we ready for the challenge of implementing risk-based breast cancer screening and primary prevention?
Linda Rainey, Daniëlle van der Waal, Anna Jervaeus, Yvonne Wengström, D Gareth Evans, Louise S Donnelly, Mireille J M Broeders. Breast 2018
18
27

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
10

Population-based screening in the era of genomics.
Nora Pashayan, Paul Pharoah. Per Med 2012
13
30

Assessing individual breast cancer risk within the U.K. National Health Service Breast Screening Program: a new paradigm for cancer prevention.
D Gareth R Evans, Jane Warwick, Susan M Astley, Paula Stavrinos, Sarah Sahin, Sarah Ingham, Helen McBurney, Barbara Eckersley, Michelle Harvie, Mary Wilson,[...]. Cancer Prev Res (Phila) 2012
68
10

Polygenic susceptibility to breast cancer and implications for prevention.
Paul D P Pharoah, Antonis Antoniou, Martin Bobrow, Ron L Zimmern, Douglas F Easton, Bruce A J Ponder. Nat Genet 2002
578
10

How can polygenic inheritance be used in population screening for common diseases?
Muin J Khoury, A Cecile J W Janssens, David F Ransohoff. Genet Med 2013
35
11

Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis.
Nora Pashayan, Stephen W Duffy, David E Neal, Freddie C Hamdy, Jenny L Donovan, Richard M Martin, Patricia Harrington, Sara Benlloch, Ali Amin Al Olama, Mitul Shah,[...]. Genet Med 2015
63
10

Combined associations of genetic and environmental risk factors: implications for prevention of breast cancer.
Montserrat Garcia-Closas, Necdet Burak Gunsoy, Nilanjan Chatterjee. J Natl Cancer Inst 2014
76
10

The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis.
Gareth J Hollands, David P French, Simon J Griffin, A Toby Prevost, Stephen Sutton, Sarah King, Theresa M Marteau. BMJ 2016
261
10

Breast cancer screening in an era of personalized regimens: a conceptual model and National Cancer Institute initiative for risk-based and preference-based approaches at a population level.
Tracy Onega, Elisabeth F Beaber, Brian L Sprague, William E Barlow, Jennifer S Haas, Anna N A Tosteson, Mitchell D Schnall, Katrina Armstrong, Marilyn M Schapira, Berta Geller,[...]. Cancer 2014
91
10

A breast cancer prediction model incorporating familial and personal risk factors.
Jonathan Tyrer, Stephen W Duffy, Jack Cuzick. Stat Med 2004
693
10

Clinician-Reported Barriers to Implementing Breast Cancer Chemoprevention in the UK: A Qualitative Investigation.
Samuel G Smith, Lucy Side, Susanne F Meisel, Rob Horne, Jack Cuzick, Jane Wardle. Public Health Genomics 2016
17
23


Population-Based Precision Cancer Screening: A Symposium on Evidence, Epidemiology, and Next Steps.
Pamela M Marcus, Nora Pashayan, Timothy R Church, V Paul Doria-Rose, Michael K Gould, Rebecca A Hubbard, Michael Marrone, Diana L Miglioretti, Paul D Pharoah, Paul F Pinsky,[...]. Cancer Epidemiol Biomarkers Prev 2016
37
10

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.
Nasim Mavaddat, Kyriaki Michailidou, Joe Dennis, Michael Lush, Laura Fachal, Andrew Lee, Jonathan P Tyrer, Ting-Huei Chen, Qin Wang, Manjeet K Bolla,[...]. Am J Hum Genet 2019
317
10

The benefits and harms of breast cancer screening: an independent review.
M G Marmot, D G Altman, D A Cameron, J A Dewar, S G Thompson, M Wilcox. Br J Cancer 2013
487
10

What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420).
David P French, Susan Astley, Adam R Brentnall, Jack Cuzick, Richard Dobrashian, Stephen W Duffy, Louise S Gorman, Elaine F Harkness, Fiona Harrison, Michelle Harvie,[...]. BMC Cancer 2020
16
25

How Do Women View Risk-Based Mammography Screening? A Qualitative Study.
Xiaofei He, Karen E Schifferdecker, Elissa M Ozanne, Anna N A Tosteson, Steven Woloshin, Lisa M Schwartz. J Gen Intern Med 2018
14
28

Attitudes towards risk-stratified breast cancer screening among women in England: A cross-sectional survey.
Alex Ghanouni, Saskia C Sanderson, Nora Pashayan, Cristina Renzi, Christian von Wagner, Jo Waller. J Med Screen 2020
15
26

Women's perceptions of personalized risk-based breast cancer screening and prevention: An international focus group study.
Linda Rainey, Anna Jervaeus, Louise S Donnelly, D Gareth Evans, Mattias Hammarström, Per Hall, Yvonne Wengström, Mireille J M Broeders, Daniëlle van der Waal. Psychooncology 2019
18
22

European women's perceptions of the implementation and organisation of risk-based breast cancer screening and prevention: a qualitative study.
Linda Rainey, Daniëlle van der Waal, Anna Jervaeus, Louise S Donnelly, D Gareth Evans, Mattias Hammarström, Per Hall, Yvonne Wengström, Mireille J M Broeders. BMC Cancer 2020
9
44

Uptake rates for breast cancer genetic testing: a systematic review.
Mary E Ropka, Jennifer Wenzel, Elayne K Phillips, Mir Siadaty, John T Philbrick. Cancer Epidemiol Biomarkers Prev 2006
117
7

A systematic review of perceived risks, psychological and behavioral impacts of genetic testing.
Jodi T Heshka, Crystal Palleschi, Heather Howley, Brenda Wilson, Philip S Wells. Genet Med 2008
228
7

Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours.
Theresa M Marteau, David P French, Simon J Griffin, A T Prevost, Stephen Sutton, Clare Watkinson, Sophie Attwood, Gareth J Hollands. Cochrane Database Syst Rev 2010
197
7

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
D Ford, D F Easton, D T Bishop, S A Narod, D E Goldgar. Lancet 1994
7

What ethical and legal principles should guide the genotyping of children as part of a personalised screening programme for common cancer?
Alison Elizabeth Hall, Susmita Chowdhury, Nora Pashayan, Nina Hallowell, Paul Pharoah, Hilary Burton. J Med Ethics 2014
12
25


Genome-based prediction of breast cancer risk in the general population: a modeling study based on meta-analyses of genetic associations.
Moniek van Zitteren, Jeroen B van der Net, Suman Kundu, Andrew N Freedman, Cornelia M van Duijn, A Cecile J W Janssens. Cancer Epidemiol Biomarkers Prev 2011
27
11

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene.
Alfons Meindl, Heide Hellebrand, Constanze Wiek, Verena Erven, Barbara Wappenschmidt, Dieter Niederacher, Marcel Freund, Peter Lichtner, Linda Hartmann, Heiner Schaal,[...]. Nat Genet 2010
473
7

Germline mutations in RAD51D confer susceptibility to ovarian cancer.
Chey Loveday, Clare Turnbull, Emma Ramsay, Deborah Hughes, Elise Ruark, Jessica R Frankum, Georgina Bowden, Bolot Kalmyrzaev, Margaret Warren-Perry, Katie Snape,[...]. Nat Genet 2011
336
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.